ETC Elektrophorese-Technik develops and manufactures high-end electrophoresis consumables and equipment used for diagnostics, quality control and species identification
Fluorotechnics is a developer and manufacturer of fluorescent research tools that are used in proteomics, cell biology and biochemistry.
Its CEO, Duncan Veal, states: "We are very excited by the synergies that the combination of the two companies will bring.
"This acquisition will allow us to cross-sell products to existing customers and to address new markets utilising our joint expertise.
"Our ever-expanding sales and marketing team and enormous potential for our product offering means that we are well positioned for strong growth".
Hanspeter Schickle, CEO of ETC, said: "We know that our customers will welcome the extended offering and complete solution that the range of Fluorotechnics and ETC products will now provide".
The merged group possesses exceptional expertise, has a dynamic product pipeline and is set to become a leading supplier to life-scientists, globally.
Rick Taylor, chairman of Fluorotechnics, said: "We are acquiring a company that greatly broadens our foothold in the expanding electrophoresis market.
"The acquisition broadens our technology horizons and stimulates the flow of new product applications.
"We believe that this development will accrue major benefits to the shareholders of both companies".
The integrated company will retain its manufacturing bases in Sydney, Australia and Kirchentellinsfurt, Germany.
Duncan Veal will continue as CEO, Hanspeter Schickle will become head of product development in electrophoresis, and Gunter Thesseling, a recent appointment from GE Healthcare, will spearhead the sales and marketing drive.
